Gainers

• Sunshine Biopharma (NASDAQ:SBFM) shares rose 94.0% to $0.55 during Monday's regular session. The market value of their outstanding shares is at $1.3 million. As per the press release, Q1 earnings came out 3 days ago.
• Virax Biolabs Group (NASDAQ:VRAX) stock increased by 85.66% to $0.28. The company's market cap stands at $1.1 million.
• Wellgistics Health (NASDAQ:WGRX) stock increased by 74.85% to $0.15. The company's market cap stands at $10.5 million.
• AIM ImmunoTech (AMEX:AIM) shares moved upwards by 74.38% to $0.44. The market value of their outstanding shares is at $3.9 million. The company's, Q1 earnings came out yesterday.
• Geovax Labs (NASDAQ:GOVX) shares moved upwards by 62.43% to $2.0. The company's market cap stands at $4.2 million. The company's, Q1 earnings came out 2 days ago.
• AEON Biopharma (AMEX:AEON) shares increased by 22.22% to $0.88. The company's market cap stands at $18.9 million. The company's, Q1 earnings came out 2 days ago.

Losers

• WORK Medical Tech Gr (NASDAQ:WOK) shares fell 45.5% to $0.36 during Monday's regular session.
• Gossamer Bio (NASDAQ:GOSS) stock fell 35.56% to $0.22. The company's market cap stands at $79.7 million. The company's, Q1 earnings came out yesterday.
• China Pharma Holding (AMEX:CPHI) shares decreased by 30.78% to $0.72. The company's market cap stands at $5.2 million. The company's, Q1 earnings came out yesterday.
• P3 Health Partners (NASDAQ:PIII) shares fell 30.47% to $7.85. The company's market cap stands at $37.5 million. As per the press release, Q1 earnings came out 2 days ago.
• Edesa Biotech (NASDAQ:EDSA) shares decreased by 30.39% to $9.09. The company's market cap stands at $108.9 million. As per the press release, Q2 earnings came out 2 days ago.
• GlucoTrack (NASDAQ:GCTK) shares decreased by 28.93% to $0.46. The company's market cap stands at $2.3 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.